Exploring REST and MMP24 levels by immunostaining or RNA sequencing in either normal tissue adjacent to the tumor or in patients with endometrial intraepithelial neoplasia will also help determine the role of these markers in pre-cancerous tissue. This evidence concerns the gene MMP24 and neoplasm.